India may firm up plans to export Bharat Biotech’s Covaxin

India has received enquiries from other countries for the export of the indigenous Covid 19 vaccine Covaxin jointly developed by Bharat Biotech and the Indian Council of Medical Research (ICMR), according to government officials aware of the development. According to Hindustan Tims, New Delhi has been approached by at least two

India to begin Phase II/III trials for Covaxin on children

Bharat Biotech is all set to begin phase II and III clinical trials for Covaxin in children in the age group of 2 to 18 years in the next 10-12 days, reports The Economic Times quoting VK Paul, Member (Health), Niti Aayog on Tuesday. "Covaxin has been approved by the Drugs